Adagio Medical Holdings, Inc. Income Statement
ADGM|2 years of annual SEC 10-K data (FY2024-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 2 fiscal years. All figures from audited SEC 10-K filings.
Adagio Medical Holdings, Inc. reported $0 in revenue and $25M in net loss for FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $0 | $333.0K |
| Cost of Revenue | $684.0K | $1.4M |
| SG&A Expense | $10.6M | $13.0M |
| R&D Expense | $10.6M | $7.6M |
| Operating Income | -$21.9M | -$21.7M |
| Income Tax | $0 | $0 |
| Net Income | -$25.1M | -$21.3M |
| EPS (Basic) | -$26.08 | -$48.16 |
| EPS (Diluted) | -$26.08 | -$48.16 |
| Shares Outstanding | 779.9K | 779.9K |
| Operating Margin | - | -6510.5% |
| Profit Margin | - | -6389.8% |